Bioelectronics Corp (BIEL)

[askjsell]

"The cash flow in 2016 will eat multiples of the 15 billion shares at current price.
With exponential growth in international sale and a piece of cake FDA clearance in 2016, share buyback can be easily implemented. 2016 is Biel's year. "

Then why the need to increase the authorized share count and dilute the float? If BIEL is expected to make lots of money...then why does the company need to see more shares?

BIEL is not going to buyback any shares...BIEL is preparing to sell 4 billion more. BIEL is selling shares...not buying anything.